Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2016 (2016), Article ID 7050613, 4 pages
http://dx.doi.org/10.1155/2016/7050613
Case Report

Progressive Multifocal Leukoencephalopathy in a HIV Negative, Immunocompetent Patient

Columbia College of Physicians and Surgeons, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY 10032, USA

Received 23 May 2016; Revised 28 June 2016; Accepted 10 July 2016

Academic Editor: Isabella Laura Simone

Copyright © 2016 T. Nanda. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Weber, C. Trebst, S. Frye et al., “Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy,” Journal of Infectious Diseases, vol. 176, no. 1, pp. 250–254, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. I. J. Koralnik, D. Schellingerhout, and M. P. Frosch, “Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits,” The New England Journal of Medicine, vol. 350, no. 18, pp. 1882–1893, 2004. View at Publisher · View at Google Scholar
  3. B. K. Kleinschmidt-DeMasters and K. L. Tyler, “Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis,” New England Journal of Medicine, vol. 353, no. 4, pp. 369–374, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Van Assche, M. Van Ranst, R. Sciot et al., “Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease,” The New England Journal of Medicine, vol. 353, no. 4, pp. 362–368, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Tavazzi, P. Ferrante, and K. Khalili, “Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies,” Clinical Microbiology and Infection, vol. 17, no. 12, pp. 1776–1780, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Tan, R. Roda, L. Ostrow, J. McArthur, and A. Nath, “PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids,” Neurology, vol. 72, no. 17, pp. 1458–1464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. I. J. Koralnik, “Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name?” Annals of Neurology, vol. 60, no. 2, pp. 162–173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. W. Ferenczy, L. J. Marshall, C. D. S. Nelson et al., “Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain,” Clinical Microbiology Reviews, vol. 25, no. 3, pp. 471–506, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. P. G. Christakis, D. Okin, A. J. Huttner, and J. M. Baehring, “Progressive multifocal leukoencephalopathy in an immunocompetent patient,” Journal of the Neurological Sciences, vol. 326, no. 1-2, pp. 107–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. K. K. Johansen, S. H. Torp, J. Rydland, and J. O. Aasly, “Progressive multifocal leukoencephalopathy in an immunocompetent patient?” Case Reports in Neurology, vol. 5, no. 3, pp. 149–154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. V. C. Gourineni, T. Juvet, Y. Kumar, D. Bordea, and K. N. Sena, “Progressive multifocal leukoencephalopathy in a 62-year-old immunocompetent woman,” Case Reports in Neurological Medicine, vol. 2014, Article ID 549271, 4 pages, 2014. View at Publisher · View at Google Scholar
  12. S. Gheuens, G. Pierone, P. Peeters, and I. J. Koralnik, “Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 81, no. 3, pp. 247–254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. A. Wahib, A. A. Masoud, A. A. Halem et al., “Cell mediated immune response in chronic liver diseases: schistosomal, viral, and neoplastic,” Journal of the Egyptian Society of Parasitology, vol. 28, pp. 929–939, 1998. View at Google Scholar
  14. R. Kim, M. Emi, and K. Tanabe, “Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity,” Immunology, vol. 119, no. 2, pp. 254–264, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Haider, D. Nafziger, J. A. Gutierrez, I. Brar, N. Mateo, and J. Fogle, “Progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia: a case report and review of reported cases,” Clinical Infectious Diseases, vol. 31, no. 4, pp. E20–E22, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Zonios, J. Falloon, J. Bennett et al., “Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors,” Blood, vol. 112, no. 2, pp. 287–294, 2008. View at Publisher · View at Google Scholar
  17. P. Hubert, F. Bergeron, V. Ferreira et al., “Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia,” International Immunology, vol. 12, no. 4, pp. 449–457, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Isgrò, M. C. Sirianni, C. Gramiccioni, I. Mezzaroma, A. Fantauzzi, and F. Aiuti, “Idiopathic CD4+ lymphocytopenia may be due to decreased bone marrow clonogenic capability,” International Archives of Allergy and Immunology, vol. 136, no. 4, pp. 379–384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. D. García de Viedma, M. Díaz Infantes, P. Miralles et al., “JC virus load in progressive multifocal leukoencephalopathy: analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival, and the volume of neurological lesions,” Clinical Infectious Diseases, vol. 34, no. 12, pp. 1568–1575, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. I. J. Koralnik, D. Boden, V. X. Mai, C. I. Lord, and N. L. Letvin, “JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy,” Neurology, vol. 52, no. 2, pp. 253–260, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Bossolasco, G. Calori, F. Moretti et al., “Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy,” Clinical Infectious Diseases, vol. 40, no. 5, pp. 738–744, 2005. View at Publisher · View at Google Scholar · View at Scopus